BCL7A Antikörper (C-Term)

Produktnummer ABIN374064

Produktdetails anti-BCL7A Antikörper

Target: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Schwein

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser BCL7A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Sequenz: C-MKLEASQQNS EEM

Spezifität: This antibody detects Bcl-7A at C-term.

Aufreinigung: Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide

Immunogen: Peptide from C Terminus of the protein Genename: BCL7A

Anwendungsinformationen

Applikationshinweise: Western Blot: 0.5-2 μg/mL. Approx 35 kDa band seen in HeLa cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.

Details zu BCL7A

Target: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Andere Bezeichnung: Bcl-7A (BCL7A Produkte)

Synonyme: BCL7 antikoerper, cb585 antikoerper, id:ibd1097 antikoerper, sb:cb585 antikoerper, wu:fk02d01 antikoerper, zgc:92023 antikoerper, 4432415N06Rik antikoerper, AI448316 antikoerper, bcl7a antikoerper, MGC89576 antikoerper, BCL7A antikoerper, BCL tumor suppressor 7A antikoerper, B-cell CLL/lymphoma 7A antikoerper, B cell CLL/lymphoma 7A antikoerper, B-cell CLL/lymphoma 7A L homeolog antikoerper, BCL7A antikoerper, bcl7a antikoerper, Bcl7a antikoerper, bcl7a.L antikoerper

Hintergrund: This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C.Synonyms: B-cell CLL/lymphoma 7 protein family member A, BCL7A

Gen-ID: 605

NCBI Accession: NP_066273

UniProt: Q4VC05